Erasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR Symposium Life Science Investing
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader Life Science Investing
Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference Life Science Investing
Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors Life Science Investing
Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds Biotech Investing
AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE Life Science Investing
Rain Enhancement Technologies to Present at H.C. Wainwright 28th Annual Global Investment Conference Life Science Investing
PRF Technologies to Establish GridFeed as a Standalone Subsidiary to Pursue Strategic Alliances for Its AI-Driven Renewable Energy Trading Platform Life Science Investing
